BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Supuran CT. Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors. J Exp Pharmacol 2020;12:603-17. [PMID: 33364855 DOI: 10.2147/JEP.S265620] [Cited by in Crossref: 40] [Cited by in F6Publishing: 51] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Oudah KH, Mahmoud WR, Awadallah FM, Taher AT, Abbas SE, Allam HA, Vullo D, Supuran CT. Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2023;38:12-23. [DOI: 10.1080/14756366.2022.2132485] [Reference Citation Analysis]
2 Supuran CT. Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities. J Enzyme Inhib Med Chem 2022;37:2478-88. [PMID: 36073149 DOI: 10.1080/14756366.2022.2121393] [Reference Citation Analysis]
3 Liguori F, Carradori S, Ronca R, Rezzola S, Filiberti S, Carta F, Turati M, Supuran CT. Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells. J Enzyme Inhib Med Chem 2022;37:1857-69. [PMID: 35768159 DOI: 10.1080/14756366.2022.2091557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Supuran CT. Carbonic Anhydrase Inhibitors from Marine Natural Products. Marine Drugs 2022;20:721. [DOI: 10.3390/md20110721] [Reference Citation Analysis]
5 Star BS, Boahen CK, van der Slikke EC, Quinten VM, ter Maaten JC, Henning RH, Kumar V, Bouma HR. Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients. Sci Rep 2022;12:19705. [DOI: 10.1038/s41598-022-22457-w] [Reference Citation Analysis]
6 Abdel‐mohsen HT, El Kerdawy AM, Petreni A, Supuran CT. Novel benzenesulfonamide‐thiouracil conjugates with a flexible N ‐ethyl acetamide linker as selective CA IX and CA XII inhibitors. Archiv der Pharmazie 2022. [DOI: 10.1002/ardp.202200434] [Reference Citation Analysis]
7 Thacker PS, Newaskar V, Angeli A, Sigalapalli DK, Goud NS, Chirra H, Shaik AB, Arifuddin M, Supuran CT. Synthesis and biological evaluation of coumarin-thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors. Arch Pharm (Weinheim) 2022;:e2200232. [PMID: 36122182 DOI: 10.1002/ardp.202200232] [Reference Citation Analysis]
8 Abdel-Mohsen HT, Omar MA, Petreni A, Supuran CT. Novel 2-substituted thioquinazoline-benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity. Arch Pharm (Weinheim) 2022;:e2200180. [PMID: 36056903 DOI: 10.1002/ardp.202200180] [Reference Citation Analysis]
9 Nguyen PL, Elkamhawy A, Choi YH, Lee CH, Lee K, Cho J. Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin. IJMS 2022;23:9903. [DOI: 10.3390/ijms23179903] [Reference Citation Analysis]
10 Abdel-Mohsen HT, Petreni A, Supuran CT. Investigation of the carbonic anhydrase inhibitory activity of benzenesulfonamides incorporating substituted fused-pyrimidine tails. Arch Pharm (Weinheim) 2022;:e2200274. [PMID: 35972823 DOI: 10.1002/ardp.202200274] [Reference Citation Analysis]
11 Maurya VK, Szwarc MM, Fernandez-Valdivia R, Lonard DM, Yong S, Joshi N, Fazleabas AT, Lydon JP. Early growth response 1 transcription factor is essential for the pathogenic properties of human endometriotic epithelial cells. Reproduction 2022;164:41-54. [PMID: 35679138 DOI: 10.1530/REP-22-0123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Hiepp L, Mayr D, Gärtner K, Schmoeckel E, Klauschen F, Burges A, Mahner S, Zeidler R, Czogalla B. Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas. PLoS ONE 2022;17:e0271630. [DOI: 10.1371/journal.pone.0271630] [Reference Citation Analysis]
13 Arrighi G, Puerta A, Petrini A, Hicke FJ, Nocentini A, Fernandes MX, Padrón JM, Supuran CT, Fernández-bolaños JG, López Ó. Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations. IJMS 2022;23:7685. [DOI: 10.3390/ijms23147685] [Reference Citation Analysis]
14 Tatari N, Zhang X, Chafe SC, Mckenna D, Lawson KA, Subapanditha M, Shaikh MV, Seyfrid M, Savage N, Venugopal C, Moffat J, Singh SK. Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors. Front Immunol 2022;13:905768. [DOI: 10.3389/fimmu.2022.905768] [Reference Citation Analysis]
15 Giovannuzzi S, Capasso C, Nocentini A, Supuran CT. Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII. Molecules 2022;27:4076. [DOI: 10.3390/molecules27134076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nerella SG, Singh P, Arifuddin M, Supuran CT. Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opin Ther Pat 2022. [PMID: 35616541 DOI: 10.1080/13543776.2022.2083502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Kciuk M, Gielecińska A, Mujwar S, Mojzych M, Marciniak B, Drozda R, Kontek R. Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. J Enzyme Inhib Med Chem 2022;37:1278-98. [PMID: 35506234 DOI: 10.1080/14756366.2022.2052868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
18 Heneberg P. Lactic Acidosis in Patients with Solid Cancer. Antioxid Redox Signal 2022. [PMID: 35316087 DOI: 10.1089/ars.2021.0267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 El-kalyoubi SA, Taher ES, Ibrahim TS, El-behairy MF, Al-mahmoudy AMM. Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline–Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors. Pharmaceuticals 2022;15:494. [DOI: 10.3390/ph15050494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Nada H, Elkamhawy A, Abdellattif MH, Angeli A, Lee CH, Supuran CT, Lee K. 4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies. J Enzyme Inhib Med Chem 2022;37:994-1004. [PMID: 35350942 DOI: 10.1080/14756366.2022.2055553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bonardi A, Bua S, Combs J, Lomelino C, Andring J, Osman SM, Toti A, Di Cesare Mannelli L, Gratteri P, Ghelardini C, Mckenna R, Nocentini A, Supuran CT. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:930-9. [DOI: 10.1080/14756366.2022.2053526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Huo Z, Bilang R, Supuran CT, von der Weid N, Bruder E, Holland-Cunz S, Martin I, Muraro MG, Gros SJ. Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma. Int J Mol Sci 2022;23:3128. [PMID: 35328549 DOI: 10.3390/ijms23063128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Merabti A, Roger M, Nguyen C, Nocentini A, Gerbier P, Richeter S, Gary‐bobo M, Supuran CT, Clément S, Winum J. Carbonic Anhydrase Inhibitors Featuring a Porphyrin Scaffold: Synthesis, Optical and Biological Properties. European J Organic Chem. [DOI: 10.1002/ejoc.202101538] [Reference Citation Analysis]
24 Abdel-Mohsen HT, El Kerdawy AM, Omar MA, Petreni A, Allam RM, El Diwani HI, Supuran CT. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Eur J Med Chem 2022;228:114004. [PMID: 34847409 DOI: 10.1016/j.ejmech.2021.114004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
25 Giovannuzzi S, D'Ambrosio M, Luceri C, Osman SM, Pallecchi M, Bartolucci G, Nocentini A, Supuran CT. Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms. Int J Mol Sci 2021;23:461. [PMID: 35008884 DOI: 10.3390/ijms23010461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Biagiotti G, Angeli A, Giacomini A, Toniolo G, Landini L, Salerno G, Di Cesare Mannelli L, Ghelardini C, Mello T, Mussi S, Ravelli C, Marelli M, Cicchi S, Menna E, Ronca R, Supuran CT, Richichi B. Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells. ACS Appl Nano Mater 2021;4:14153-60. [PMID: 34970641 DOI: 10.1021/acsanm.1c03603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mussi S, Rezzola S, Chiodelli P, Nocentini A, Supuran CT, Ronca R. Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines. J Enzyme Inhib Med Chem 2022;37:280-6. [PMID: 34894950 DOI: 10.1080/14756366.2021.2004592] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
28 Supuran CT. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2021;:1-12. [PMID: 34865569 DOI: 10.1080/13543784.2021.2014813] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 16.0] [Reference Citation Analysis]
29 Zhou Y, Wu YJ, Wang L, Han J, Wu JC, Li CM, Wang Y. Natural deep eutectic solvents as green and biocompatible reaction medium for carbonic anhydrase catalysis. Int J Biol Macromol 2021;190:206-13. [PMID: 34492243 DOI: 10.1016/j.ijbiomac.2021.08.221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
30 Mikulová MB, Kružlicová D, Pecher D, Petreni A, Supuran CT, Mikuš P. Synthesis and Inhibition Activity Study of Triazinyl-Substituted Amino(alkyl)-benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Human Carbonic Anhydrases I, II, IV, IX, and XII. Int J Mol Sci 2021;22:11283. [PMID: 34681940 DOI: 10.3390/ijms222011283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Di Fiore A, Supuran CT, Scaloni A, De Simone G. Post-translational modifications in tumor-associated carbonic anhydrases. Amino Acids 2021. [PMID: 34436666 DOI: 10.1007/s00726-021-03063-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Güttler A, Eiselt Y, Funtan A, Thiel A, Petrenko M, Keßler J, Thondorf I, Paschke R, Vordermark D, Bache M. Betulin Sulfonamides as Carbonic Anhydrase Inhibitors and Anticancer Agents in Breast Cancer Cells. Int J Mol Sci 2021;22:8808. [PMID: 34445506 DOI: 10.3390/ijms22168808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Mancuso F, Di Fiore A, De Luca L, Angeli A, De Simone G, Supuran CT, Gitto R. Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII. Bioorg Med Chem 2021;44:116279. [PMID: 34216985 DOI: 10.1016/j.bmc.2021.116279] [Reference Citation Analysis]
34 Supuran CT, Nocentini A, Yakubova E, Savchuk N, Kalinin S, Krasavin M. Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms. J Enzyme Inhib Med Chem 2021;36:1056-60. [PMID: 34000969 DOI: 10.1080/14756366.2021.1927007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Mishra CB, Mongre RK, Prakash A, Jeon R, Supuran CT, Lee MS. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies. J Enzyme Inhib Med Chem 2021;36:954-63. [PMID: 33947294 DOI: 10.1080/14756366.2021.1909580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 De Luca V, Petreni A, Carginale V, Scaloni A, Supuran CT, Capasso C. Effect of amino acids and amines on the activity of the recombinant ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021;36:1000-6. [PMID: 33980103 DOI: 10.1080/14756366.2021.1919891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Supuran CT. Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. J Enzyme Inhib Med Chem 2021;36:1702-14. [PMID: 34325588 DOI: 10.1080/14756366.2021.1945049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
38 Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561-80. [PMID: 33615947 DOI: 10.1080/14756366.2021.1882453] [Cited by in Crossref: 34] [Cited by in F6Publishing: 44] [Article Influence: 34.0] [Reference Citation Analysis]
39 Tsikas D, Gambaryan S. Nitrous anhydrase activity of carbonic anhydrase II: cysteine is required for nitric oxide (NO) dependent phosphorylation of VASP in human platelets. J Enzyme Inhib Med Chem 2021;36:525-34. [PMID: 33508993 DOI: 10.1080/14756366.2021.1874946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Temiz E, Koyuncu I, Durgun M, Caglayan M, Gonel A, Güler EM, Kocyigit A, Supuran CT. Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells. Int J Mol Sci 2021;22:6098. [PMID: 34198834 DOI: 10.3390/ijms22116098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
41 Zhang ZP, Zhong Y, Han ZB, Zhou L, Su HS, Wang J, Liu Y, Cheng MS. Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives. Int J Mol Sci 2021;22:5482. [PMID: 34067452 DOI: 10.3390/ijms22115482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Mondal UK, Doroba K, Shabana AM, Adelberg R, Alam MR, Supuran CT, Ilies MA. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX. Int J Mol Sci 2021;22:1120. [PMID: 33498779 DOI: 10.3390/ijms22031120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Supuran CT. A Story on Carbon Dioxide and Its Hydration. New Trends in Macromolecular and Supramolecular Chemistry for Biological Applications 2021. [DOI: 10.1007/978-3-030-57456-7_6] [Reference Citation Analysis]